KẾT QUẢ PHẪU THUẬT NỘI SOI SAU PHÚC MẠC ĐIỀU TRỊ U TUYẾN THƯỢNG THẬN TẠI BỆNH VIỆN E

Abstract

Objective: To describe the clinical and paraclinical characteristics and to evaluate the surgical outcomes of retroperitoneoscopic adrenal tumor resection; to compare surgical outcomes between total adrenalectomy and adrenal-sparing surgery; and to investigate several factors related to the feasibility of adrenal preservation. Methods: A cross-sectional descriptive study. Results: A total of 32 patients undergoing retroperitoneoscopic adrenal tumor resection were included in the study. The mean age was 48.9 ± 15.8 years, with no significant difference in sex distribution. Most patients were incidentally diagnosed or presented with hypertension, accounting for 84.4%. The mean tumor size was 3.5 ± 2.2 cm, the mean operative time was 76.6 ± 15.3 minutes. Intraoperative and postoperative outcomes, including operative time, length of hospital stay, duration of drainage, estimated blood loss, and complication rates, were comparable between the total adrenalectomy group and the adrenal-sparing group, with no statistically significant differences (p > 0.05). Conclusion: Retroperitoneoscopic surgery is a safe, minimally invasive, and effective approach for the treatment of adrenal tumors. Short-term outcomes suggest that adrenal-sparing surgery is technically feasible and provides comparable intraoperative and postoperative clinical results to total adrenalectomy in the management of adrenal tumors. Further large-scale randomized controlled studies are required to further validate the safety and efficacy of these two approaches.